Hadas Shasha-Lavsky

chronic Health cin Jewish Holocaust s urvivors Born during w orld w ar ii

L. Keinan-Boker, S. Shasha, Hadas Shasha-Lavsky, 2015 .

Chronic health conditions in Jewish Holocaust survivors born during World War II.

L. Keinan-Boker, S. Shasha, Hadas Shasha-Lavsky, 2015, The Israel Medical Association journal : IMAJ.

Treatment and long-term outcome in primary distal renal tubular acidosis.

F. Trepiccione, G. Gambaro, Z. Gucev, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children.

D. Magen, Y. Frishberg, T. Mcgregor, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

Wilms’ Tumor Gene 1: A Possible New Proangiogenic Factor in Hodgkin Lymphoma

Yuval Nov, M. Lurie, D. Attias, 2012, Applied immunohistochemistry & molecular morphology : AIMM.

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.

J. Lieske, D. Magen, M. Sweetser, 2021, The New England journal of medicine.

Long-term outcomes after pre-emptive liver transplantation in primary hyperoxaluria type 1

A. Dror, L. Kalfon, I. Weissman, 2022, Pediatric Nephrology.

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial

D. Magen, M. Sweetser, Y. Frishberg, 2022, Pediatric Nephrology.